Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

COMPLETED NA

The HIP Impact Protection Program (HIP PRO)

NCT00058864 · View on ClinicalTrials.gov ↗

Study Summary

HIP PRO is a multicenter randomized, controlled trial of an energy absorbing and distributing padding system designed to reduce the incidence of hip fractures in 546 nursing home (NH) residents. The trial is being conducted in three geographic regions of the US: Boston, St. Louis, and Baltimore. Non bed- or chair-bound residents over the age of 65 are given protective underwear containing a single pocket and hip pad so that each resident becomes his/her own control. During the trial, hip fracture incidence will be compared in padded and unpadded hips using an intent to treat analysis. A secondary aim is to identify resident and facility factors contributing to non-adherence with the use of the hip protector.

Conditions Studied

Interventions

  • DEVICE Energy absorbing and distributing trochanteric pad

Study Locations (4)

Maryland

  • University of Maryland, Baltimore — Baltimore
  • Maryland Medical Research Institute — Baltimore

Massachusetts

  • Hebrew Rehabilitation Center for Aged Research and Training Institute — Boston

Missouri

  • Washington University School of Medicine, Division of Geriatrics & Gerontology — St Louis

Trial Details

FieldValue
Enrollment Target 546 participants
Start Date 2001-09
Est. Completion 2006-08
Phase NA

Sponsor

National Institute on Aging (NIA)

127 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00058864

The ClinicalTrials.gov registry entry for NCT00058864 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 546 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 127 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Hip Fractures appearing as the primary indexed condition, and to 1 intervention — of which Energy absorbing and distributing trochanteric pad is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT00058864 reports 4 study locations spanning 3 distinct geographic areas — top geographies include Maryland, Massachusetts, Missouri. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT00058864 about?

NCT00058864 is a clinical study titled "The HIP Impact Protection Program (HIP PRO)". HIP PRO is a multicenter randomized, controlled trial of an energy absorbing and distributing padding system designed to reduce the incidence of hip fractures in 546 nursing home (NH) residents. The trial is being conducted in three geographic regions of the US: Boston, St. Louis, and Baltimore. Non...

What is the current status of trial NCT00058864?

This trial is currently completed. It is a NA study. The enrollment target is 546 participants. The study started on 2001-09. Estimated completion is 2006-08.

What conditions does trial NCT00058864 study?

This clinical trial studies the following conditions: Hip Fractures. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT00058864?

The interventions under investigation include: Energy absorbing and distributing trochanteric pad (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT00058864?

This trial is sponsored by National Institute on Aging (NIA), which has 127 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT00058864 being conducted?

This trial has 4 study locations across Maryland, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial